Ruth M. O'Regan, MD, and Anna Weiss, MD, join the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss the treatment of early-stage node-negative triple-negative breast cancer (TNBC).
Treatment Algorithms in Triple-Negative Breast Cancer: How to Apply them to Clinical Practice
The expert panel provides clinical insights on treating patients with high-risk or locally advanced triple-negative breast cancer.
Ruth M. O’Regan, MD, and Anna Weiss, MD, discuss treatment paradigms for patients with metastatic triple-negative breast cancer and the role of surgery.
A panel of medical oncologists provides insights on managing toxicities in patients with triple-negative breast cancer who are receiving antibody-drug conjugates.
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Giredestrant Displays IDFS Improvement vs SOC ET in ER+/HER2– BC
2
Sacituzumab Govitecan Does Not Meet Statistical Significance in HR+/HER2– mBC
3
QOL Improvements Noted After CAR T-Cell Therapy in LBCL
4
Lower CRS Enables Outpatient Use of Anito-cel in R/R Multiple Myeloma
5
